Title:
【発明の名称】NF-κBの活性化を阻害することにより治療上の影響を与えることができる、ヒトおよび動物における病気を治療するための医薬を製造するためのR-アリールプロピオン酸の使用
Document Type and Number:
Japanese Patent JP2002537325
Kind Code:
A
Abstract:
The invention relates to the use of R-antimers of aryl propionic acids or aryl propionic acid derivatives for producing medicaments that inhibit the NF- kappa B activation cascade. Said medicaments are therefore suitable for treating diseases that can be positively influenced by the inhibition of NF- kappa B formation from a therapeutic standpoint.
Inventors:
Gerd Geislinger
Kai Brunet
Kai Brunet
Application Number:
JP2000600631A
Publication Date:
November 05, 2002
Filing Date:
January 17, 2000
Export Citation:
Assignee:
P.A.Z.Erznai Mittel Entwicungs Gesellschaft Mitt Beschlenktel Haftung
International Classes:
A61K31/00; A61K31/192; A61P39/00; (IPC1-7): A61K31/192; A61K9/22; A61K9/28; A61P1/00; A61P1/04; A61P7/08; A61P9/10; A61P11/06; A61P25/28; A61P29/00; A61P35/00; A61P37/00; A61P37/06; A61P39/00; A61P43/00
Foreign References:
| WO1998047502A1 | 1998-10-29 |
Attorney, Agent or Firm:
Toshio Yano (4 outside)